[go: up one dir, main page]

EA200901179A1 - Замещённые тетрагидрохинолины - Google Patents

Замещённые тетрагидрохинолины

Info

Publication number
EA200901179A1
EA200901179A1 EA200901179A EA200901179A EA200901179A1 EA 200901179 A1 EA200901179 A1 EA 200901179A1 EA 200901179 A EA200901179 A EA 200901179A EA 200901179 A EA200901179 A EA 200901179A EA 200901179 A1 EA200901179 A1 EA 200901179A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tetrahydrochinolines
substituted
tumors
compounds
formula
Prior art date
Application number
EA200901179A
Other languages
English (en)
Inventor
Кай Шиманн
Дирк Финзингер
Кристиане Амендт
Франк Ценке
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA200901179A1 publication Critical patent/EA200901179A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Соединения формулы (I)в которой R, R, R, R, R, X, Y, W, Q, Q, Z, s и m имеют значения, указанные в п.1, могут применяться, в частности, для лечения опухолей.
EA200901179A 2007-03-20 2008-02-21 Замещённые тетрагидрохинолины EA200901179A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007013855A DE102007013855A1 (de) 2007-03-20 2007-03-20 Substituierte Tetrahydrochinoline
PCT/EP2008/001353 WO2008113451A1 (de) 2007-03-20 2008-02-21 Substituierte tetrahydrochinoline

Publications (1)

Publication Number Publication Date
EA200901179A1 true EA200901179A1 (ru) 2010-04-30

Family

ID=39456401

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901179A EA200901179A1 (ru) 2007-03-20 2008-02-21 Замещённые тетрагидрохинолины

Country Status (16)

Country Link
US (1) US8524732B2 (ru)
EP (1) EP2121700B1 (ru)
JP (1) JP5480636B2 (ru)
KR (1) KR20090120005A (ru)
CN (1) CN101641362A (ru)
AR (1) AR065787A1 (ru)
AU (1) AU2008228565B2 (ru)
BR (1) BRPI0808938A2 (ru)
CA (1) CA2681256C (ru)
DE (1) DE102007013855A1 (ru)
EA (1) EA200901179A1 (ru)
ES (1) ES2394535T3 (ru)
IL (1) IL200964A (ru)
MX (1) MX2009009916A (ru)
WO (1) WO2008113451A1 (ru)
ZA (1) ZA200907305B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011084439A1 (en) * 2009-12-17 2011-07-14 Sanofi Tetrahydrocarboline derivatives as eg5 inhibitors
US9263716B2 (en) * 2013-02-21 2016-02-16 Lutron Electronics Co., Inc. Monolithic battery holder having resilient retention strap for use in battery-powered sensor
US9498540B2 (en) 2013-03-15 2016-11-22 Novartis Ag Cell proliferation inhibitors and conjugates thereof
CN107801396B (zh) 2015-02-02 2021-10-22 福马治疗股份有限公司 作为hdac抑制剂的3-芳基-4-酰氨基-二环[4,5,0]异羟肟酸
WO2016126726A1 (en) 2015-02-02 2016-08-11 Forma Therapeutics, Inc. Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors
EP3472131B1 (en) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US5428051A (en) 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
ATE167181T1 (de) 1993-12-09 1998-06-15 Ono Pharmaceutical Co Naphthylessigsäurederivate als pgez agonisten und antagonisten
US5521189A (en) 1994-05-06 1996-05-28 The University Of Nc At Ch Methods of treating pneumocystis carinii pneumonia
US5602172A (en) 1994-05-06 1997-02-11 The University Of North Carolina At Chapel Hill Methods of inhibiting Pneumocystis carinii pneumonia, Giardia lamblia, and Cryptosporidium and compounds useful therefor
US5643935A (en) 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles
US5723495A (en) 1995-11-16 1998-03-03 The University Of North Carolina At Chapel Hill Benzamidoxime prodrugs as antipneumocystic agents
WO2000010990A2 (en) 1998-08-20 2000-03-02 University Of North Carolina At Chapel Hill Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
EP1143959B1 (en) 1998-09-17 2006-11-02 University Of North Carolina At Chapel Hill Antifungal activity of dicationic molecules
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
AU4972900A (en) 1999-04-08 2000-11-14 Arch Development Corporation Use of anti-vegf antibody to enhance radiation in cancer therapy
DE60034063T2 (de) 1999-07-08 2007-07-26 University Of North Carolina At Chapel Hill Neue prodrugs für antimicrobielle amidine
US6325395B1 (en) 2000-02-07 2001-12-04 Jeffrey L. Frymoyer Wheeled buoyant decoy transporting device
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US7250423B2 (en) 2001-09-24 2007-07-31 Chao-Jun Li Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers
EP2033959B1 (de) * 2003-12-20 2011-04-27 Merck Patent GmbH Tetrahydropyranochinolinderivate
DE102005027170A1 (de) * 2005-06-13 2006-12-14 Merck Patent Gmbh Substituierte Tetrahydrochinoline
JP4655821B2 (ja) * 2005-08-23 2011-03-23 株式会社日立製作所 脳機能計測用刺激呈示装置

Also Published As

Publication number Publication date
CA2681256C (en) 2015-06-02
CN101641362A (zh) 2010-02-03
AU2008228565A1 (en) 2008-09-25
IL200964A (en) 2016-10-31
MX2009009916A (es) 2009-10-19
DE102007013855A1 (de) 2008-09-25
IL200964A0 (en) 2010-05-17
JP2010521503A (ja) 2010-06-24
AU2008228565B2 (en) 2012-09-20
BRPI0808938A2 (pt) 2014-08-19
ZA200907305B (en) 2010-06-30
EP2121700A1 (de) 2009-11-25
KR20090120005A (ko) 2009-11-23
CA2681256A1 (en) 2008-09-25
EP2121700B1 (de) 2012-10-03
ES2394535T3 (es) 2013-02-01
US8524732B2 (en) 2013-09-03
JP5480636B2 (ja) 2014-04-23
WO2008113451A1 (de) 2008-09-25
US20100022579A1 (en) 2010-01-28
AR065787A1 (es) 2009-07-01

Similar Documents

Publication Publication Date Title
EA201000558A1 (ru) Производные имидазола
EA201100880A1 (ru) Бензонафтиридиновые соединения в качестве ингибиторов аутотаксина
EA201000549A1 (ru) Производные пиперидина и пиперазина
EA201000550A1 (ru) Производные тиазола
EA200901611A1 (ru) Производные 2-оксо-3-бензил-бензоксазол-2-она и родственные соединения в качестве ингибиторов мет киназы для лечения опухолей
EA200901601A1 (ru) Производные пиридазинона
EA201000094A1 (ru) Производные пиримидинил-пиридазинона
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA201200119A1 (ru) Гетероциклические соединения в качестве ингибиторов аутотаксина
EA201001005A1 (ru) Производные 2-бензилпиридазинона в качестве ингибиторов мет киназы
EA200901603A1 (ru) Арил-эфирные производные пиридазинона
EA201100966A1 (ru) Производные пиридазинона
EA201000618A1 (ru) 5-цианотиенопиридины для лечения опухолей
EA201100035A1 (ru) Производные тиазолилпиперидина
EA201200653A1 (ru) Гетариламинохинолины
EA201000004A1 (ru) Производные 6-(пирролопиридинил)пиримидин-2-иламина и их применение для лечения злокачественного новообразования и спида
NO20071127L (no) Triazoloftalaziner
EA201001648A1 (ru) Производные пиридазинона
EA201101041A1 (ru) Производные пиридазинона
EA201001576A1 (ru) Тиенопиримидины
EA201001348A1 (ru) Пирролопиримидинкарбоксамиды
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5